Global Biosimilar Monoclonal Antibodies Market Growth 2020-2025
According to this study, over the next five years the Biosimilar Monoclonal Antibodies market will register a 28.7%% CAGR in terms of revenue, the global market size will reach $ 12290 million by 2025, from $ 4474.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilar Monoclonal Antibodies business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Monoclonal Antibodies market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Biosimilar Monoclonal Antibodies, covering the supply chain analysis, impact assessment to the Biosimilar Monoclonal Antibodies market size growth rate in several scenarios, and the measures to be undertaken by Biosimilar Monoclonal Antibodies companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Autoimmune Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Celltrion
Pfizer (Hospira)
Novartis (Sandoz)
Dr Reddy’s
3SBIO
Hisun Pharma
Celgen Biopharma
Torrent Pharmaceuticals
Cadila Healthcare
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biosimilar Monoclonal Antibodies consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Biosimilar Monoclonal Antibodies market by identifying its various subsegments.
Focuses on the key global Biosimilar Monoclonal Antibodies manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biosimilar Monoclonal Antibodies with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biosimilar Monoclonal Antibodies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Monoclonal Antibodies Consumption 2015-2025
2.1.2 Biosimilar Monoclonal Antibodies Consumption CAGR by Region
2.2 Biosimilar Monoclonal Antibodies Segment by Type
2.2.1 Infliximab
2.2.2 Rituximab
2.2.3 Trastuzumab
2.2.4 Adalimumab
2.2.5 Other
2.3 Biosimilar Monoclonal Antibodies Consumption by Type
2.3.1 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
2.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2015-2020)
2.3.3 Global Biosimilar Monoclonal Antibodies Sale Price by Type (2015-2020)
2.4 Biosimilar Monoclonal Antibodies Segment by Application
2.4.1 Oncology
2.4.2 Autoimmune Disease
2.4.3 Other
2.5 Biosimilar Monoclonal Antibodies Consumption by Application
2.5.1 Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
2.5.2 Global Biosimilar Monoclonal Antibodies Value and Market Share by Type (2015-2020)
2.5.3 Global Biosimilar Monoclonal Antibodies Sale Price by Type (2015-2020)
3 Global Biosimilar Monoclonal Antibodies by Company
3.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Company
3.1.1 Global Biosimilar Monoclonal Antibodies Sales by Company (2018-2020)
3.1.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Company (2018-2020)
3.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company
3.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Company (2018-2020)
3.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2018-2020)
3.3 Global Biosimilar Monoclonal Antibodies Sale Price by Company
3.4 Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Biosimilar Monoclonal Antibodies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Biosimilar Monoclonal Antibodies by Regions
4.1 Biosimilar Monoclonal Antibodies by Regions
4.2 Americas Biosimilar Monoclonal Antibodies Consumption Growth
4.3 APAC Biosimilar Monoclonal Antibodies Consumption Growth
4.4 Europe Biosimilar Monoclonal Antibodies Consumption Growth
4.5 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Growth
5 Americas
5.1 Americas Biosimilar Monoclonal Antibodies Consumption by Countries
5.1.1 Americas Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020)
5.1.2 Americas Biosimilar Monoclonal Antibodies Value by Countries (2015-2020)
5.2 Americas Biosimilar Monoclonal Antibodies Consumption by Type
5.3 Americas Biosimilar Monoclonal Antibodies Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Biosimilar Monoclonal Antibodies Consumption by Regions
6.1.1 APAC Biosimilar Monoclonal Antibodies Consumption by Regions (2015-2020)
6.1.2 APAC Biosimilar Monoclonal Antibodies Value by Regions (2015-2020)
6.2 APAC Biosimilar Monoclonal Antibodies Consumption by Type
6.3 APAC Biosimilar Monoclonal Antibodies Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Biosimilar Monoclonal Antibodies by Countries
7.1.1 Europe Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020)
7.1.2 Europe Biosimilar Monoclonal Antibodies Value by Countries (2015-2020)
7.2 Europe Biosimilar Monoclonal Antibodies Consumption by Type
7.3 Europe Biosimilar Monoclonal Antibodies Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Monoclonal Antibodies by Countries
8.1.1 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Biosimilar Monoclonal Antibodies Value by Countries (2015-2020)
8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Type
8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biosimilar Monoclonal Antibodies Distributors
10.3 Biosimilar Monoclonal Antibodies Customer
11 Global Biosimilar Monoclonal Antibodies Market Forecast
11.1 Global Biosimilar Monoclonal Antibodies Consumption Forecast (2021-2025)
11.2 Global Biosimilar Monoclonal Antibodies Forecast by Regions
11.2.1 Global Biosimilar Monoclonal Antibodies Forecast by Regions (2021-2025)
11.2.2 Global Biosimilar Monoclonal Antibodies Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biosimilar Monoclonal Antibodies Forecast by Type
11.8 Global Biosimilar Monoclonal Antibodies Forecast by Application
12 Key Players Analysis
12.1 Celltrion
12.1.1 Company Information
12.1.2 Biosimilar Monoclonal Antibodies Product Offered
12.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Celltrion Latest Developments
12.2 Pfizer (Hospira)
12.2.1 Company Information
12.2.2 Biosimilar Monoclonal Antibodies Product Offered
12.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Pfizer (Hospira) Latest Developments
12.3 Novartis (Sandoz)
12.3.1 Company Information
12.3.2 Biosimilar Monoclonal Antibodies Product Offered
12.3.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Novartis (Sandoz) Latest Developments
12.4 Dr Reddy’s
12.4.1 Company Information
12.4.2 Biosimilar Monoclonal Antibodies Product Offered
12.4.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Dr Reddy’s Latest Developments
12.5 3SBIO
12.5.1 Company Information
12.5.2 Biosimilar Monoclonal Antibodies Product Offered
12.5.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 3SBIO Latest Developments
12.6 Hisun Pharma
12.6.1 Company Information
12.6.2 Biosimilar Monoclonal Antibodies Product Offered
12.6.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Hisun Pharma Latest Developments
12.7 Celgen Biopharma
12.7.1 Company Information
12.7.2 Biosimilar Monoclonal Antibodies Product Offered
12.7.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Celgen Biopharma Latest Developments
12.8 Torrent Pharmaceuticals
12.8.1 Company Information
12.8.2 Biosimilar Monoclonal Antibodies Product Offered
12.8.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Torrent Pharmaceuticals Latest Developments
12.9 Cadila Healthcare
12.9.1 Company Information
12.9.2 Biosimilar Monoclonal Antibodies Product Offered
12.9.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Cadila Healthcare Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Biosimilar Monoclonal Antibodies Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Infliximab
Table 5. Major Players of Rituximab
Table 6. Major Players of Trastuzumab
Table 7. Major Players of Adalimumab
Table 8. Major Players of Other
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Table 11. Global Biosimilar Monoclonal Antibodies Revenue by Type (2015-2020) ($ million)
Table 12. Global Biosimilar Monoclonal Antibodies Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Biosimilar Monoclonal Antibodies Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Table 16. Global Biosimilar Monoclonal Antibodies Value by Application (2015-2020)
Table 17. Global Biosimilar Monoclonal Antibodies Value Market Share by Application (2015-2020)
Table 18. Global Biosimilar Monoclonal Antibodies Sale Price by Application (2015-2020)
Table 19. Global Biosimilar Monoclonal Antibodies Sales by Company (2017-2019) (K Units)
Table 20. Global Biosimilar Monoclonal Antibodies Sales Market Share by Company (2017-2019)
Table 21. Global Biosimilar Monoclonal Antibodies Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2017-2019)
Table 23. Global Biosimilar Monoclonal Antibodies Sale Price by Company (2017-2019)
Table 24. Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Biosimilar Monoclonal Antibodies Products Offered
Table 26. Biosimilar Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Biosimilar Monoclonal Antibodies Consumption by Regions 2015-2020 (K Units)
Table 28. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Regions 2015-2020
Table 29. Global Biosimilar Monoclonal Antibodies Value by Regions 2015-2020 ($ Millions)
Table 30. Global Biosimilar Monoclonal Antibodies Value Market Share by Regions 2015-2020
Table 31. Americas Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2015-2020)
Table 33. Americas Biosimilar Monoclonal Antibodies Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Biosimilar Monoclonal Antibodies Value Market Share by Countries (2015-2020)
Table 35. Americas Biosimilar Monoclonal Antibodies Consumption by Type (2015-2020) (K Units)
Table 36. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Table 37. Americas Biosimilar Monoclonal Antibodies Consumption by Application (2015-2020) (K Units)
Table 38. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Table 39. APAC Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020) (K Units)
Table 40. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2015-2020)
Table 41. APAC Biosimilar Monoclonal Antibodies Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Biosimilar Monoclonal Antibodies Value Market Share by Regions (2015-2020)
Table 43. APAC Biosimilar Monoclonal Antibodies Consumption by Type (2015-2020) (K Units)
Table 44. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Table 45. APAC Biosimilar Monoclonal Antibodies Consumption by Application (2015-2020) (K Units)
Table 46. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Table 47. Europe Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2015-2020)
Table 49. Europe Biosimilar Monoclonal Antibodies Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Biosimilar Monoclonal Antibodies Value Market Share by Countries (2015-2020)
Table 51. Europe Biosimilar Monoclonal Antibodies Consumption by Type (2015-2020) (K Units)
Table 52. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Table 53. Europe Biosimilar Monoclonal Antibodies Consumption by Application (2015-2020) (K Units)
Table 54. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Biosimilar Monoclonal Antibodies Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Biosimilar Monoclonal Antibodies Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Table 63. Biosimilar Monoclonal Antibodies Distributors List
Table 64. Biosimilar Monoclonal Antibodies Customer List
Table 65. Global Biosimilar Monoclonal Antibodies Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Biosimilar Monoclonal Antibodies Consumption Market Forecast by Regions
Table 67. Global Biosimilar Monoclonal Antibodies Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Biosimilar Monoclonal Antibodies Value Market Share Forecast by Regions
Table 69. Global Biosimilar Monoclonal Antibodies Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Biosimilar Monoclonal Antibodies Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Biosimilar Monoclonal Antibodies Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Biosimilar Monoclonal Antibodies Value Market Share Forecast by Type (2021-2025)
Table 73. Global Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Biosimilar Monoclonal Antibodies Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Biosimilar Monoclonal Antibodies Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Biosimilar Monoclonal Antibodies Value Market Share Forecast by Application (2021-2025)
Table 77. Celltrion Product Offered
Table 78. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 79. Celltrion Main Business
Table 80. Celltrion Latest Developments
Table 81. Celltrion Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 82. Pfizer (Hospira) Product Offered
Table 83. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 84. Pfizer (Hospira) Main Business
Table 85. Pfizer (Hospira) Latest Developments
Table 86. Pfizer (Hospira) Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 87. Novartis (Sandoz) Product Offered
Table 88. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 89. Novartis (Sandoz) Main Business
Table 90. Novartis (Sandoz) Latest Developments
Table 91. Novartis (Sandoz) Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 92. Dr Reddy’s Product Offered
Table 93. Dr Reddy’s Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 94. Dr Reddy’s Main Business
Table 95. Dr Reddy’s Latest Developments
Table 96. Dr Reddy’s Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 97. 3SBIO Product Offered
Table 98. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 99. 3SBIO Main Business
Table 100. 3SBIO Latest Developments
Table 101. 3SBIO Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 102. Hisun Pharma Product Offered
Table 103. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 104. Hisun Pharma Main Business
Table 105. Hisun Pharma Latest Developments
Table 106. Hisun Pharma Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 107. Celgen Biopharma Product Offered
Table 108. Celgen Biopharma Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 109. Celgen Biopharma Main Business
Table 110. Celgen Biopharma Latest Developments
Table 111. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Torrent Pharmaceuticals Product Offered
Table 113. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 114. Torrent Pharmaceuticals Main Business
Table 115. Torrent Pharmaceuticals Latest Developments
Table 116. Torrent Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 117. Cadila Healthcare Product Offered
Table 118. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 119. Cadila Healthcare Main Business
Table 120. Cadila Healthcare Latest Developments
Table 121. Cadila Healthcare Basic Information, Company Total Revenue (in $ million), Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Biosimilar Monoclonal Antibodies
Figure 2. Biosimilar Monoclonal Antibodies Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Biosimilar Monoclonal Antibodies Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Biosimilar Monoclonal Antibodies Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Infliximab
Figure 7. Product Picture of Rituximab
Figure 8. Product Picture of Trastuzumab
Figure 9. Product Picture of Adalimumab
Figure 10. Product Picture of Other
Figure 11. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Type (2015-2020)
Figure 12. Global Biosimilar Monoclonal Antibodies Value Market Share by Type (2015-2020)
Figure 13. Biosimilar Monoclonal Antibodies Consumed in Oncology
Figure 14. Global Biosimilar Monoclonal Antibodies Market: Oncology (2015-2020) (K Units)
Figure 15. Global Biosimilar Monoclonal Antibodies Market: Oncology (2015-2020) ($ Millions)
Figure 16. Biosimilar Monoclonal Antibodies Consumed in Autoimmune Disease
Figure 17. Global Biosimilar Monoclonal Antibodies Market: Autoimmune Disease (2015-2020) (K Units)
Figure 18. Global Biosimilar Monoclonal Antibodies Market: Autoimmune Disease (2015-2020) ($ Millions)
Figure 19. Biosimilar Monoclonal Antibodies Consumed in Other
Figure 20. Global Biosimilar Monoclonal Antibodies Market: Other (2015-2020) (K Units)
Figure 21. Global Biosimilar Monoclonal Antibodies Market: Other (2015-2020) ($ Millions)
Figure 22. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Figure 23. Global Biosimilar Monoclonal Antibodies Value Market Share by Application (2015-2020)
Figure 24. Global Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2017
Figure 25. Global Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 26. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company in 2017
Figure 27. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company in 2019
Figure 28. Global Biosimilar Monoclonal Antibodies Sale Price by Company in 2019
Figure 29. Global Biosimilar Monoclonal Antibodies Consumption Market Share by Regions 2015-2020
Figure 30. Global Biosimilar Monoclonal Antibodies Value Market Share by Regions 2015-2020
Figure 31. Americas Biosimilar Monoclonal Antibodies Consumption 2015-2020 (K Units)
Figure 32. Americas Biosimilar Monoclonal Antibodies Value 2015-2020 ($ Millions)
Figure 33. APAC Biosimilar Monoclonal Antibodies Consumption 2015-2020 (K Units)
Figure 34. APAC Biosimilar Monoclonal Antibodies Value 2015-2020 ($ Millions)
Figure 35. Europe Biosimilar Monoclonal Antibodies Consumption 2015-2020 (K Units)
Figure 36. Europe Biosimilar Monoclonal Antibodies Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption 2015-2020 (K Units)
Figure 38. Middle East & Africa Biosimilar Monoclonal Antibodies Value 2015-2020 ($ Millions)
Figure 39. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2019
Figure 40. Americas Biosimilar Monoclonal Antibodies Value Market Share by Countries in 2019
Figure 41. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2019
Figure 42. Americas Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2019
Figure 43. United States Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 44. United States Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 46. Canada Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 48. Mexico Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2019
Figure 50. APAC Biosimilar Monoclonal Antibodies Value Market Share by Regions in 2019
Figure 51. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2019
Figure 52. APAC Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2019
Figure 53. China Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 54. China Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 56. Japan Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 58. Korea Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 60. Southeast Asia Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 61. India Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 62. India Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 64. Australia Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2019
Figure 66. Europe Biosimilar Monoclonal Antibodies Value Market Share by Countries in 2019
Figure 67. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2019
Figure 68. Europe Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2019
Figure 69. Germany Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 70. Germany Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 71. France Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 72. France Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 73. UK Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 74. UK Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 76. Italy Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 78. Russia Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Biosimilar Monoclonal Antibodies Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption Market Share by Application in 2019
Figure 83. Egypt Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 84. Egypt Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 86. South Africa Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 88. Israel Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 90. Turkey Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Biosimilar Monoclonal Antibodies Consumption Growth 2015-2020 (K Units)
Figure 92. GCC Countries Biosimilar Monoclonal Antibodies Value Growth 2015-2020 ($ Millions)
Figure 93. Global Biosimilar Monoclonal Antibodies Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 94. Global Biosimilar Monoclonal Antibodies Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 96. Americas Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 97. APAC Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 98. APAC Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 99. Europe Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 100. Europe Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 102. Middle East & Africa Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 103. United States Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 104. United States Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 105. Canada Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 106. Canada Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 107. Mexico Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 108. Mexico Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 109. Brazil Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 110. Brazil Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 111. China Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 112. China Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 113. Japan Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 114. Japan Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 115. Korea Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 116. Korea Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 118. Southeast Asia Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 119. India Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 120. India Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 121. Australia Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 122. Australia Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 123. Germany Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 124. Germany Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 125. France Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 126. France Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 127. UK Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 128. UK Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 129. Italy Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 130. Italy Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 131. Russia Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 132. Russia Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 133. Spain Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 134. Spain Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 135. Egypt Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 136. Egypt Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 137. South Africa Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 138. South Africa Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 139. Israel Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 140. Israel Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 141. Turkey Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 142. Turkey Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Biosimilar Monoclonal Antibodies Consumption 2021-2025 (K Units)
Figure 144. GCC Countries Biosimilar Monoclonal Antibodies Value 2021-2025 ($ Millions)
Figure 145. Celltrion Biosimilar Monoclonal Antibodies Market Share (2018-2020)
Figure 146. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Market Share (2018-2020)
Figure 147. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Market Share (2018-2020)
Figure 148. Dr Reddy’s Biosimilar Monoclonal Antibodies Market Share (2018-2020)
Figure 149. 3SBIO Biosimilar Monoclonal Antibodies Market Share (2018-2020)
Figure 150. Hisun Pharma Biosimilar Monoclonal Antibodies Market Share (2018-2020)
Figure 151. Celgen Biopharma Biosimilar Monoclonal Antibodies Market Share (2018-2020)
Figure 152. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Market Share (2018-2020)
Figure 153. Cadila Healthcare Biosimilar Monoclonal Antibodies Market Share (2018-2020)
